Tuesday, April 29, 2008


[The deliberate contamination of this product, which many people depend on, took place in China. You got that folks? CHINA!]

Tue Apr 29, 2008 11:32am EDT
WASHINGTON (Reuters) - The contamination of Baxter International Inc's blood-thinner heparin appears to have been deliberate, the company's chief executive said in testimony prepared for a congressional hearing on Tuesday.

"We're alarmed that one of our products was used, in what appears to have been a deliberate scheme, to adulterate a life-saving medication, and that people have suffered as a result," Baxter Chief Executive Robert Parkinson said.

"We deeply regret that this has happened, and I feel a strong sense of personal responsibility for these circumstances," he said.

(Reporting by Lisa Richwine; editing by John Wallace)

© Thomson Reuters 2008. All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only.

No comments: